Section Arrow
Quote
TOI.NASDAQ
- Oncology Institute (The)
Quotes are at least 15-min delayed:2026/07/27 18:07 EDT
After Hours
Last
 5.26
+0.07 (+1.35%)
Bid
5.19
Ask
5.55
High 5.29 
Low 5.19 
Volume 24.08K 
Regular Hours (Closed)
Last
 5.19
+0.21 (+4.22%)
Day High 
5.32 
Prev. Close
4.98 
1-M High
6.67 
Volume 
1.45M 
Bid
5.19
Ask
5.55
Day Low
5.03 
Open
5.03 
1-M Low
4.9612 
Market Cap 
497.92M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.51 
20-SMA 5.55 
50-SMA 5.05 
52-W High 6.67 
52-W Low 2.32 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.35/-0.16
Enterprise Value
594.45M
Balance Sheet
Book Value Per Share
-0.16
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
502.73M
Operating Revenue Per Share
2.93
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BKDBrookdale Senior Living15.47+0.32+2.11%-- 
After Hours 15.55 +0.08 +0.52%
ACHCAcadia Healthcare Company32.5-2.01-5.82%-- 
After Hours 32.5 0 0.00%
CMPSCOMPASS Pathways Plc11.27+0.01+0.09%-- 
After Hours 11.23 -0.04 -0.35%
THCTenet Healthcare Corp243.36+10.16+4.36%12.13PE
After Hours 243 -0.36 -0.15%
OPCHOption Care Health21.81+0.15+0.69%16.92PE
After Hours 21.81 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.